Skip Navigation

A Phase I/II Trial Evaluating the Safety and Efficacy of Eribulin in Combination with Copanlisib in Patients with Metastatic Triple Negative Breast Cancer

Brief Summary

Type:
Breast Cancer

Study Type:
Treatment

Phase:
I/II

ClinicalTrials.gov Identifier:
NCT04345913

Study #:
STUDY00150131

Start Date:
Jun 05, 2023

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04345913

View Complete Trial Details & Eligibility at ClinicalTrials.gov